Professional Overview
Glenn Goddard is a seasoned financial executive currently serving as the Chief Financial Officer at Auron Therapeutics, Inc. in Andover, Massachusetts. His key expertise areas include financial management, strategic planning, and leadership, with a strong industry focus on biotechnology and therapeutics.
Experience Summary
Current Role
As the Chief Financial Officer at Auron Therapeutics, Inc., Glenn oversees all financial aspects of the company, including financial planning, budgeting, and fundraising. His key responsibilities include developing and implementing financial strategies, managing financial operations, and ensuring compliance with regulatory requirements. Although specific achievements in this role are not available, his experience and expertise are expected to significantly impact the company's financial performance and industry standing.
Career Progression
Glenn's career progression is marked by notable roles in various biotechnology companies. Before joining Auron Therapeutics, Inc., he served as the EVP, Chief Financial Officer at Intellia Therapeutics, Inc. and as a Board Member and Audit Committee Chair at AvenCell. Earlier in his career, he held positions such as Chief Financial Officer at Generation Bio, Senior Vice President Finance/Principal Financial Officer at Agios, VP of Finance at Archemix, Controller at ImmunoGen, Accounting Manager at Dragon Systems, Audit Senior at Ernst & Young, and Audit Supervisor at Feeley & Driscoll, P.C. These roles demonstrate his career trajectory and growth, with key achievements including successful financial management, strategic planning, and leadership.
Areas of Expertise
Glenn's areas of expertise include:
- Financial management and planning
- Strategic planning and execution
- Leadership and team management
- Financial operations and compliance
- Industry-specific knowledge in biotechnology and therapeutics
Professional Impact
Although specific projects or initiatives led by Glenn are not detailed, his contributions to the biotechnology industry are evident through his roles in various companies. His experience and expertise have likely influenced the financial performance and strategic direction of these organizations.
Conclusion
Glenn Goddard's professional trajectory is characterized by a strong background in financial management and leadership within the biotechnology industry. Currently, as the Chief Financial Officer at Auron Therapeutics, Inc., he is focused on driving financial growth and strategic planning. His value proposition lies in his ability to provide strategic financial leadership, ensuring the company's success and contribution to the industry.
